r-51211

Itraconazole (R51211) is a triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes necessary for ERGOSTEROL synthesis.

Itraconazole-D3 (Standard) is a reference standard of Itraconazole-D3 intended for quantitative analysis, quality control, and related biochemical research applications. Itraconazole-d3 is a deuterated compound of Itraconazole.

Itraconazole (Standard) is a reference standard for research and analysis in studies involving Itraconazole. Itraconazole (R51211) belongs to the triazole group of natural products and is an antifungal agent with oral activity. Itraconazole is a Hedgehog signaling pathway antagonist, an oxysterol-binding protein (OSBP) inhibitor, and an inhibitor of cytochrome P-450-dependent enzymes.

Itraconazole-D5 (Standard) is a reference standard of Itraconazole-D5 intended for quantitative analysis, quality control, and related biochemical research applications. Itraconazole-d5 is a deuterated compound of Itraconazole. Itraconazole has a CAS number of 84625-61-6. Itraconazole is a triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.

Itraconazole-D9 is the deuterated form of Itraconazole. Itraconazole (T1011) (R51211) is a triazole antifungal agent with potent oral activity as a Hedgehog signaling pathway antagonist, exhibiting an IC50 of approximately 800 nM. It effectively inhibits lanosterol 14α-demethylase (Cytochrome P450), thus preventing the conversion of lanosterol to ergosterol. Additionally, Itraconazole (T1011) exhibits anti-cancer and anti-angiogenic properties and acts as an oxysterol-binding protein (OSBP) inhibitor.

Itraconazole-D5 is a deuterated compound of Itraconazole. Itraconazole (T1011) has a CAS number of 84625-61-6. Itraconazole (T1011) is a triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.

Itraconazole-D3 is a deuterated compound of Itraconazole (T1011).